nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—TYMS—ovarian cancer	0.821	1	CbGaD
Trifluridine—TK1—epithelium—ovarian cancer	0.00575	0.0704	CbGeAlD
Trifluridine—TK1—Nucleotide metabolism—NME2—ovarian cancer	0.00562	0.0658	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—NME2—ovarian cancer	0.00556	0.0651	CbGpPWpGaD
Trifluridine—TK1—endometrium—ovarian cancer	0.00516	0.0631	CbGeAlD
Trifluridine—TK1—uterus—ovarian cancer	0.00475	0.0582	CbGeAlD
Trifluridine—TK1—female reproductive system—ovarian cancer	0.00427	0.0523	CbGeAlD
Trifluridine—TK1—bone marrow—ovarian cancer	0.00403	0.0494	CbGeAlD
Trifluridine—TYMP—myometrium—ovarian cancer	0.00391	0.0478	CbGeAlD
Trifluridine—TYMP—Nucleotide metabolism—NME2—ovarian cancer	0.00389	0.0456	CbGpPWpGaD
Trifluridine—TK1—female gonad—ovarian cancer	0.00389	0.0476	CbGeAlD
Trifluridine—TK1—vagina—ovarian cancer	0.00386	0.0473	CbGeAlD
Trifluridine—TK1—testis—ovarian cancer	0.00345	0.0422	CbGeAlD
Trifluridine—TK1—Pyrimidine metabolism—TYMS—ovarian cancer	0.00327	0.0383	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—RBL2—ovarian cancer	0.00306	0.0359	CbGpPWpGaD
Trifluridine—TYMP—uterine cervix—ovarian cancer	0.00304	0.0372	CbGeAlD
Trifluridine—TYMP—decidua—ovarian cancer	0.0029	0.0354	CbGeAlD
Trifluridine—TYMP—endometrium—ovarian cancer	0.00275	0.0336	CbGeAlD
Trifluridine—TYMS—uterine cervix—ovarian cancer	0.00261	0.0319	CbGeAlD
Trifluridine—TK1—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.00254	0.0297	CbGpPWpGaD
Trifluridine—TYMP—uterus—ovarian cancer	0.00253	0.031	CbGeAlD
Trifluridine—TK1—lymph node—ovarian cancer	0.0025	0.0306	CbGeAlD
Trifluridine—TYMS—Docetaxel—Paclitaxel—ovarian cancer	0.00248	0.472	CbGdCrCtD
Trifluridine—TYMS—endometrium—ovarian cancer	0.00236	0.0289	CbGeAlD
Trifluridine—Cladribine—NR5A1—ovarian cancer	0.00235	0.347	CrCbGaD
Trifluridine—TYMP—female reproductive system—ovarian cancer	0.00228	0.0279	CbGeAlD
Trifluridine—TYMP—Pyrimidine metabolism—TYMS—ovarian cancer	0.00227	0.0266	CbGpPWpGaD
Trifluridine—Zidovudine—TERT—ovarian cancer	0.00225	0.333	CrCbGaD
Trifluridine—TYMS—gonad—ovarian cancer	0.00219	0.0268	CbGeAlD
Trifluridine—TYMP—bone marrow—ovarian cancer	0.00215	0.0263	CbGeAlD
Trifluridine—TYMP—female gonad—ovarian cancer	0.00207	0.0254	CbGeAlD
Trifluridine—TYMP—vagina—ovarian cancer	0.00206	0.0252	CbGeAlD
Trifluridine—TYMS—Nucleotide metabolism—NME2—ovarian cancer	0.00199	0.0233	CbGpPWpGaD
Trifluridine—TYMS—female reproductive system—ovarian cancer	0.00195	0.0239	CbGeAlD
Trifluridine—Floxuridine—TYMS—ovarian cancer	0.00192	0.284	CrCbGaD
Trifluridine—TYMS—bone marrow—ovarian cancer	0.00184	0.0226	CbGeAlD
Trifluridine—TYMP—testis—ovarian cancer	0.00184	0.0225	CbGeAlD
Trifluridine—TYMS—female gonad—ovarian cancer	0.00178	0.0218	CbGeAlD
Trifluridine—TYMS—vagina—ovarian cancer	0.00177	0.0216	CbGeAlD
Trifluridine—TYMP—Fluoropyrimidine Activity—TYMS—ovarian cancer	0.00176	0.0206	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—SLC2A1—ovarian cancer	0.00163	0.0191	CbGpPWpGaD
Trifluridine—TYMS—testis—ovarian cancer	0.00158	0.0193	CbGeAlD
Trifluridine—TK1—E2F transcription factor network—BRCA1—ovarian cancer	0.00156	0.0183	CbGpPWpGaD
Trifluridine—TYMS—G1/S-Specific Transcription—CCNE1—ovarian cancer	0.00156	0.0182	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—CCND2—ovarian cancer	0.00147	0.0172	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CCNE1—ovarian cancer	0.00137	0.016	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—TYMS—ovarian cancer	0.00134	0.0157	CbGpPWpGaD
Trifluridine—TYMP—lymph node—ovarian cancer	0.00133	0.0163	CbGeAlD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.00129	0.0151	CbGpPWpGaD
Trifluridine—TK1—Nucleotide metabolism—TYMS—ovarian cancer	0.00127	0.0149	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CDH1—ovarian cancer	0.00125	0.0146	CbGpPWpGaD
Trifluridine—TYMS—Paclitaxel—Docetaxel—ovarian cancer	0.00124	0.236	CbGdCrCtD
Trifluridine—TYMS—lymph node—ovarian cancer	0.00114	0.014	CbGeAlD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—BIRC5—ovarian cancer	0.00113	0.0133	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TERT—ovarian cancer	0.0011	0.0129	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—RBL2—ovarian cancer	0.00109	0.0127	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—ERBB2—ovarian cancer	0.00105	0.0123	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CXCL8—ovarian cancer	0.000998	0.0117	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—PPP2R1A—ovarian cancer	0.000986	0.0116	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CCND1—ovarian cancer	0.00093	0.0109	CbGpPWpGaD
Trifluridine—TYMS—E2F mediated regulation of DNA replication—CCNE1—ovarian cancer	0.000915	0.0107	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—TYMS—ovarian cancer	0.000883	0.0103	CbGpPWpGaD
Trifluridine—TYMS—Vincristine—Vinorelbine—ovarian cancer	0.000852	0.162	CbGdCrCtD
Trifluridine—TK1—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000841	0.00985	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—VEGFA—ovarian cancer	0.000811	0.0095	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.000769	0.00901	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MYC—ovarian cancer	0.000746	0.00874	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MAPK1—ovarian cancer	0.00073	0.00855	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—EGFR—ovarian cancer	0.00073	0.00855	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDKN1B—ovarian cancer	0.000709	0.00831	CbGpPWpGaD
Trifluridine—TYMS—Vinblastine—Vinorelbine—ovarian cancer	0.000685	0.13	CbGdCrCtD
Trifluridine—TYMS—Mitotic G1-G1/S phases—RBL2—ovarian cancer	0.000664	0.00778	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.000628	0.00736	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.000627	0.00734	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MMP9—ovarian cancer	0.000616	0.00722	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—TP53—ovarian cancer	0.000613	0.00718	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TOP1—ovarian cancer	0.000602	0.00705	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—HRAS—ovarian cancer	0.000586	0.00687	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000583	0.00683	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—BRCA1—ovarian cancer	0.000554	0.00649	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—MYC—ovarian cancer	0.000543	0.00636	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—PPP1CC—ovarian cancer	0.000526	0.00616	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—SKP2—ovarian cancer	0.000524	0.00614	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RSF1—ovarian cancer	0.000516	0.00605	CbGpPWpGaD
Trifluridine—TK1—Metabolism—NME2—ovarian cancer	0.00051	0.00598	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MYC—ovarian cancer	0.000509	0.00597	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CCNE1—ovarian cancer	0.000485	0.00568	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—HNF1B—ovarian cancer	0.000456	0.00534	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—SKP2—ovarian cancer	0.000442	0.00518	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.000421	0.00494	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TP53—ovarian cancer	0.000418	0.0049	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—PPP2R1A—ovarian cancer	0.000379	0.00444	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—NME2—ovarian cancer	0.000354	0.00414	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CCNE1—ovarian cancer	0.000352	0.00412	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND2—ovarian cancer	0.000339	0.00397	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYTB—ovarian cancer	0.000329	0.00385	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—PPP2R1A—ovarian cancer	0.000319	0.00374	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.0003	0.00351	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—TP53—ovarian cancer	0.000298	0.00349	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCNE1—ovarian cancer	0.000297	0.00347	CbGpPWpGaD
Trifluridine—TK1—Metabolism—BRIP1—ovarian cancer	0.000287	0.00337	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PPP1CC—ovarian cancer	0.000287	0.00337	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000274	0.00321	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RAD51C—ovarian cancer	0.000271	0.00318	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—PPP1CC—ovarian cancer	0.000265	0.00311	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000257	0.00301	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN1B—ovarian cancer	0.000251	0.00295	CbGpPWpGaD
Trifluridine—Zidovudine—ABCB1—ovarian cancer	0.000245	0.0363	CrCbGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—RBL2—ovarian cancer	0.000244	0.00285	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—PPP1CC—ovarian cancer	0.000237	0.00278	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000232	0.00272	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYTB—ovarian cancer	0.000228	0.00267	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000225	0.00263	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000225	0.00263	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000218	0.00256	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—RBL2—ovarian cancer	0.000218	0.00255	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000208	0.00244	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PPP1CC—ovarian cancer	0.000199	0.00233	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—BRIP1—ovarian cancer	0.000199	0.00233	CbGpPWpGaD
Trifluridine—TK1—Metabolism—YAP1—ovarian cancer	0.000193	0.00226	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—MYC—ovarian cancer	0.000192	0.00225	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—CDKN1B—ovarian cancer	0.000182	0.00214	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—NME2—ovarian cancer	0.000181	0.00212	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000171	0.00201	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000167	0.00196	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—SKP2—ovarian cancer	0.000162	0.0019	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000162	0.0019	CbGpPWpGaD
Trifluridine—TK1—Metabolism—FASN—ovarian cancer	0.000157	0.00184	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000157	0.00184	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000156	0.00183	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SLC5A5—ovarian cancer	0.000155	0.00181	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	0.000154	0.0018	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000151	0.00177	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.00015	0.00176	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SLC2A1—ovarian cancer	0.000149	0.00175	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND1—ovarian cancer	0.000147	0.00172	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MLH1—ovarian cancer	0.000147	0.00172	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—SKP2—ovarian cancer	0.000145	0.0017	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP1B1—ovarian cancer	0.000143	0.00168	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—MYC—ovarian cancer	0.00014	0.00164	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000137	0.00161	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—YAP1—ovarian cancer	0.000134	0.00157	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PPP2R1A—ovarian cancer	0.000127	0.00149	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000126	0.00147	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND2—ovarian cancer	0.000124	0.00146	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000119	0.00139	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CHEK2—ovarian cancer	0.000118	0.00139	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ABCB1—ovarian cancer	0.000118	0.00138	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYC—ovarian cancer	0.000118	0.00138	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	0.000117	0.00137	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYTB—ovarian cancer	0.000117	0.00137	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000116	0.00136	CbGpPWpGaD
Trifluridine—TK1—Metabolism—TYMS—ovarian cancer	0.000116	0.00136	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000114	0.00134	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000111	0.0013	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BRCA1—ovarian cancer	0.000111	0.0013	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND2—ovarian cancer	0.000111	0.0013	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.00011	0.00129	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—FASN—ovarian cancer	0.000109	0.00128	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCNE1—ovarian cancer	0.000109	0.00127	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000107	0.00126	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC5A5—ovarian cancer	0.000107	0.00126	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—PPP2R1A—ovarian cancer	0.000105	0.00123	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC2A1—ovarian cancer	0.000103	0.00121	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—PTEN—ovarian cancer	0.000103	0.00121	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—BRIP1—ovarian cancer	0.000102	0.00119	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PPP1CC—ovarian cancer	0.000102	0.00119	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BRCA2—ovarian cancer	0.0001	0.00118	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP1B1—ovarian cancer	9.92e-05	0.00116	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCNE1—ovarian cancer	9.73e-05	0.00114	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	9.69e-05	0.00113	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—BIRC5—ovarian cancer	9.61e-05	0.00113	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CAV1—ovarian cancer	9.33e-05	0.00109	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	9.16e-05	0.00107	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	8.91e-05	0.00104	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PPP2R1A—ovarian cancer	8.8e-05	0.00103	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	8.72e-05	0.00102	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	8.72e-05	0.00102	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BIRC5—ovarian cancer	8.59e-05	0.00101	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CG—ovarian cancer	8.49e-05	0.000995	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TERT—ovarian cancer	8.32e-05	0.000975	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	8.23e-05	0.000965	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ABCB1—ovarian cancer	8.17e-05	0.000957	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—TYMS—ovarian cancer	8.02e-05	0.00094	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.93e-05	0.000929	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.65e-05	0.000897	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.57e-05	0.000886	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CD—ovarian cancer	7.47e-05	0.000875	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	7.32e-05	0.000858	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TP53—ovarian cancer	7.03e-05	0.000823	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—YAP1—ovarian cancer	6.83e-05	0.000801	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CB—ovarian cancer	6.51e-05	0.000763	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CAV1—ovarian cancer	6.46e-05	0.000757	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—IL6—ovarian cancer	6.43e-05	0.000754	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.18e-05	0.000724	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.04e-05	0.000708	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CG—ovarian cancer	5.89e-05	0.00069	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	5.64e-05	0.000661	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTEN—ovarian cancer	5.62e-05	0.000659	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—FASN—ovarian cancer	5.57e-05	0.000653	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC5A5—ovarian cancer	5.48e-05	0.000642	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND1—ovarian cancer	5.38e-05	0.00063	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC2A1—ovarian cancer	5.29e-05	0.00062	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CD—ovarian cancer	5.18e-05	0.000606	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP1B1—ovarian cancer	5.07e-05	0.000595	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1B—ovarian cancer	5.04e-05	0.000591	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CCND1—ovarian cancer	4.81e-05	0.000564	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CB—ovarian cancer	4.51e-05	0.000529	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PPP2R1A—ovarian cancer	4.5e-05	0.000527	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MAPK3—ovarian cancer	4.44e-05	0.00052	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYC—ovarian cancer	4.31e-05	0.000506	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MAPK1—ovarian cancer	4.22e-05	0.000495	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ABCB1—ovarian cancer	4.18e-05	0.00049	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CA—ovarian cancer	3.97e-05	0.000465	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MAPK3—ovarian cancer	3.97e-05	0.000465	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTEN—ovarian cancer	3.9e-05	0.000457	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYC—ovarian cancer	3.86e-05	0.000452	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MAPK1—ovarian cancer	3.77e-05	0.000442	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CAV1—ovarian cancer	3.31e-05	0.000387	CbGpPWpGaD
Trifluridine—TK1—Metabolism—AKT1—ovarian cancer	3.24e-05	0.00038	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TP53—ovarian cancer	3.17e-05	0.000371	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CG—ovarian cancer	3.01e-05	0.000353	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CA—ovarian cancer	2.75e-05	0.000322	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CD—ovarian cancer	2.65e-05	0.00031	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CB—ovarian cancer	2.31e-05	0.00027	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—AKT1—ovarian cancer	2.25e-05	0.000263	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTEN—ovarian cancer	1.99e-05	0.000234	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CA—ovarian cancer	1.41e-05	0.000165	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—AKT1—ovarian cancer	1.15e-05	0.000135	CbGpPWpGaD
